Both in Pharmaceuticals
Johnson & Johnson vs Pfizer
Over the past year JNJ returned +46.7% and PFE returned +23.8%; their daily moves had a correlation of 0.34.
JNJ +46.7% PFE +23.8%Growth of $1, one year, split-adjusted
| Metric | JNJ | PFE |
|---|---|---|
| Price | $273.20 | $30.52 |
| Market cap | $657.68B | $173.95B |
| Today | −0.73% | +1.90% |
| 1 month | +5.6% | +8.5% |
| 6 months | +20.3% | +15.9% |
| Year to date | +32.0% | +22.6% |
| 1 year | +46.4% | +25.6% |
| Revenue growth (YoY) | +5.9% | +2.6% |
| Gross margin | 68.1% | 72.8% |
| Net margin | 0.8% | −1.6% |
| P/E (TTM) | 40.9× | 40.2× |
| Price / sales | 6.6× | 2.7× |
| Net cash | -$27.42B | -$51.49B |
| Dividend yield | 1.96% | 5.64% |
| Volatility (60d) | 23.4% | 19.8% |
| Short % of float | 0.7% | 2.4% |
| Next earnings | — | Nov 3, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).